Sonoma Pharmaceuticals, Inc. (SNOA)
1.32
-0.01
(-0.75%)
USD |
NASDAQ |
Sep 09, 16:00
1.32
0.00 (0.00%)
After-Hours: 17:28
Sonoma Pharmaceuticals Shareholders Equity (Quarterly) : 6.594M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.594M |
| March 31, 2026 | 3.095M |
| December 31, 2025 | 3.432M |
| September 30, 2025 | 3.787M |
| June 30, 2025 | 4.056M |
| March 31, 2025 | 4.411M |
| December 31, 2024 | 4.87M |
| September 30, 2024 | 5.352M |
| June 30, 2024 | 4.975M |
| March 31, 2024 | 6.137M |
| December 31, 2023 | 6.692M |
| September 30, 2023 | 5.675M |
| June 30, 2023 | 7.242M |
| March 31, 2023 | 7.977M |
| December 31, 2022 | 5.559M |
| September 30, 2022 | 7.021M |
| June 30, 2022 | 7.959M |
| March 31, 2022 | 8.697M |
| December 31, 2021 | 11.17M |
| September 30, 2021 | 11.46M |
| June 30, 2021 | 4.621M |
| March 31, 2021 | 5.363M |
| December 31, 2020 | 12.32M |
| September 30, 2020 | 11.56M |
| June 30, 2020 | 10.66M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.624M |
| December 31, 2019 | 11.21M |
| September 30, 2019 | 10.27M |
| June 30, 2019 | 11.50M |
| March 31, 2019 | 10.49M |
| December 31, 2018 | 13.34M |
| September 30, 2018 | 10.78M |
| June 30, 2018 | 12.63M |
| March 31, 2018 | 15.33M |
| December 31, 2017 | 14.26M |
| September 30, 2017 | 16.16M |
| June 30, 2017 | 18.61M |
| March 31, 2017 | 21.43M |
| December 31, 2016 | 22.86M |
| September 30, 2016 | 6.039M |
| June 30, 2016 | 7.75M |
| March 31, 2016 | 10.14M |
| December 31, 2015 | 9.118M |
| September 30, 2015 | 10.75M |
| June 30, 2015 | 11.14M |
| March 31, 2015 | 12.05M |
| December 31, 2014 | 7.828M |
| September 30, 2014 | 13.37M |
| June 30, 2014 | 13.40M |
| March 31, 2014 | 12.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.11M |
| Total Liabilities (Quarterly) | 11.51M |
| Debt to Equity Ratio | 0.1121 |
| Current Ratio | 2.987 |
| Net Debt Paydown Yield | -1.47% |